In short, artesunate inhibits the activation of M1 macrophages and the RIPK1/RIPK3/MLKL signalling pathway by down‐regulating the expression of Mincle, thus reducing the inflammatory response and necroptosis, and further improving the renal injury of AKI. Here, RIPK3 is linked to acute kidney injury.